title: Menopausal Hormone Therapy: Current Considerations.
abstract: Menopausal hormone therapy (MHT) is the most effective treatment for vasomotor and vaginal symptoms. Today, symptomatic women younger than 60 years of age or less than 10 years since onset of menopause yield the greatest benefit of MHT with the lowest risks when compared with older women remote from menopause. Careful assessment before initiating therapy includes severity of bothersome symptoms, treatment preferences, medical history, presence of contraindications to MHT, and personal risk of cardiovascular disease and breast cancer. Considerations of type of MHT, dosing, and route of administration, and recommendations regarding duration of therapy are discussed.
authors: Department of Medicine, University of California, San Diego, School of Medicine, 6376 Castejon Drive, La Jolla, CA 92037, USA. Electronic address: castuenkel@ucsd.edu.
authors: Cynthia A
authors: CA
authors: Stuenkel
mesh_terms: D002318:Cardiovascular Diseases / Q000517:prevention & control*; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D008593:Menopause / Q000187:drug effects*; D057240:Patient Preference; D018570:Risk Assessment
keywords: Bazedoxifene; Estrogen; Menopausal hormone therapy; Ospemifene; Progestogen; Selective estrogen receptor modulator